Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
| Status: | Recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/11/2012 |
| Start Date: | February 2010 |
| Contact: | Mark R Manemann, BS, CCRP |
| Email: | manemann.mark@mayo.edu |
| Phone: | 507-284-3369 |
This research study is being done to collect regular and routine follow-up information
related to the outcome of treatment for prostate cancer.
This study is also being done to relate treatment outcome to measurement of substances in
the blood such as prostate-specific antigen (PSA) and other markers. Also environmental and
genetic factors that might be responsible for prostate cancer are being investigated.
Inclusion Criteria:
1. Informed consent explained and signed prior to any study related procedures.
2. Age ≥18 years
3. Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better, or
Karnofsky performance of 60% or better.
4. Histologically confirmed adenocarcinoma of the prostate within 10 years of study
entry.
5. Willingness to return to Mayo Clinic Rochester for follow-up or participate in
mail-in PSA processing.
6. Must be disease-free from a previous diagnosis of cancer for a period of time = 5
years excluding cutaneous malignancies of squamous cell or basal cell carcinoma.
Exclusion Criteria:
1. Life expectancy < 5 years.
2. Inability to return to Mayo Rochester for follow-up appointments, sera, and urine
collection per protocol.
3. Previous or a concurrent diagnosis of cancers other than basal cell or invasive
squamous cell carcinoma of skin within the past 5 years.
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
